selective FXR partial agonist

orally efficacious in NASH models

from two 3M compound HTS and LBD

J. Med. Chem., Jan. 15, 2020

Novartis (GNF), San Diego, CA

LMB763 (nidufexor)

LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: